Dexketoprofeno Stada

Quick links

Choose a section

Quick links to important sections

Advertisements

Dexketoprofeno Stada

Advertisements
Advertisements

Overview of Dexketoprofeno Stada

What is Dexketoprofeno Stada?

Dexketoprofeno Stada is a pharmaceutical formulation containing dexketoprofen trometamol, a medicinal substance used to manage pain. It belongs to a group of medications known as non-steroidal anti-inflammatory drugs (NSAIDs).

Classification and Mechanism

As an NSAID, dexketoprofen functions by inhibiting the synthesis of prostaglandins in the body. Prostaglandins are naturally occurring chemicals that play a central role in the inflammatory process and the transmission of pain signals. By reducing the production of these substances, the medication helps to alleviate discomfort and reduce inflammation.

Dexketoprofen is the S(+)-enantiomer of ketoprofen. In pharmacology, this specific isomer is responsible for the analgesic activity of the compound, allowing for the therapeutic effect to be achieved with a lower total dose compared to the racemic mixture.

General Uses

This medication is primarily indicated for the treatment of mild to moderate acute pain. Common applications include:

  • Musculoskeletal pain: Such as back pain, sprains, or joint discomfort.
  • Dysmenorrhea: Pain associated with menstrual cycles.
  • Dental pain: Discomfort resulting from dental issues or procedures.

Composition

Dexketoprofeno Stada is typically presented as a salt (dexketoprofen trometamol) which is highly soluble in water. This solubility profile allows for rapid absorption by the body after administration, leading to a relatively quick onset of action for pain relief.

Regulatory References

  1. NIH MedlinePlus
Advertisements

What side effects are possible with Dexketoprofeno Stada?

Possible Side Effects and Safety Information

The safety profile for this medicine is characterized by adverse reactions classified by frequency and grouped into System-Organ Classes (SOC) as defined by official regulatory authorities. These classifications demonstrate expertise in interpreting official safety data, presenting information neutrally and based on procedural understanding of how adverse effects are grouped in regulatory documents.

Adverse Reaction Classification

Adverse reactions associated with the active ingredient, dexketoprofen, are organized based on their documented incidence in clinical use, adhering to regulatory standards.

Classification Examples of Officially Documented Effects
Common Nausea, vomiting, abdominal pain, dyspepsia, headache, dizziness.
Uncommon Gastritis, constipation, dry mouth, insomnia, rash, peripheral oedema.
Rare Peptic ulcer, gastrointestinal bleeding or perforation, urticaria, hepatic damage.
Very Rare Anaphylactic reaction (including shock), acute renal failure, severe skin reactions.

Serious Adverse Reactions and Safety Patterns

The official labeling documents highlight several serious adverse reactions, including the risks of gastrointestinal haemorrhage, perforation, or ulceration, and severe hypersensitivity events such as anaphylactic shock and Stevens-Johnson Syndrome. Gastrointestinal adverse events are officially noted to be more frequent at the start of treatment.

Safety considerations for specific populations are documented: older adults have a documented increased frequency of adverse reactions, particularly serious gastrointestinal events. Furthermore, the medicine is formally constrained from use in individuals with severe cardiac, renal, or hepatic impairment.

Advertisements

Overdose and Emergency Response

Documented Manifestations and Severe Outcomes

Immediate medical attention is required upon the suspicion of a Dexketoprofeno Stada overdose due to the potential for severe, life-threatening complications outlined in regulatory documentation. Acute toxicity primarily affects two systems: the Gastrointestinal (GI) System and the Central Nervous System (CNS).

Common documented GI manifestations include nausea, vomiting (potentially bloody), diarrhea, and abdominal pain. CNS effects may present as headache, dizziness, drowsiness, confusion, and agitation. The official profile lists severe, potentially fatal outcomes, including Gastrointestinal Perforation and significant bleeding, Acute Renal Failure, and major CNS events such as Seizures and Coma. Elderly patients and individuals with pre-existing renal or hepatic impairment are documented to be at increased risk of severe adverse reactions from toxicity.

Required Emergency Response and Management

  • Mandatory Action: If an overdose is suspected, contact emergency services or a national Poison Help hotline immediately. The product container must be taken to the hospital.
  • Antidote Status: No specific antidote is known for Dexketoprofen; therefore, management is symptomatic and supportive.
  • Management: For recent, significant ingestion, medical providers may perform gastric decontamination procedures such as the administration of activated charcoal or gastric lavage.
  • Monitoring: Required procedures include continuous monitoring of vital signs, organ function, and diagnostic tests such as an ECG and blood/urine tests.
Advertisements

Therapeutic Uses of Dexketoprofeno Stada

What Dexketoprofeno Stada Treats: Main Uses and Benefits

Dexketoprofeno Stada is an oral medication belonging to the class of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). It is primarily utilized for its analgesic (pain-relieving) and anti-inflammatory properties in the management of acute pain conditions.

Primary Indications

The medication is indicated for the short-term symptomatic treatment of mild to moderate acute pain. Common applications include:

  • Musculoskeletal Pain: Relief of pain associated with muscle strains, sprains, and joint inflammation.
  • Postoperative Pain: Management of discomfort following minor surgical procedures or dental interventions.
  • Dysmenorrhea: Relief of painful menstrual cramping.
  • Dental Pain: Treatment of acute toothaches and discomfort resulting from dental inflammation.

Mechanism and Benefits

As an NSAID, the active ingredient works by inhibiting the production of prostaglandins, which are chemicals in the body that signal pain and promote inflammation at the site of injury. By reducing the concentration of these substances, the medication helps to alleviate the sensation of pain and reduce localized swelling.

The primary benefits of this treatment include:

  • Rapid Absorption: The formulation allows for the active substance to reach peak concentrations in the bloodstream relatively quickly, which is beneficial for addressing acute pain episodes.
  • Targeted Relief: It provides focused action on inflammatory pathways, making it effective for pain that involves tissue swelling or mechanical strain.
  • Short-Term Efficacy: It is designed to bridge the gap during the most intense phase of acute pain, providing stability until the underlying cause begins to resolve.
Advertisements

Eligibility and Restrictions for Use

Who Can and Cannot Use Dexketoprofeno Stada?

This section outlines the official eligibility criteria for using this medicine, based on regulatory information from government health authorities.


Contraindicated Populations (Must Not Use)

Use of Dexketoprofeno Stada is absolutely forbidden if you have:

  • Hypersensitivity to the drug, other non-steroidal anti-inflammatory drugs (NSAIDs), or any excipient. This includes individuals whose asthma, rhinitis, or urticaria is triggered by aspirin or other NSAIDs.
  • Active or a history of peptic ulcer, gastrointestinal bleeding, or perforation.
  • Severe organ impairment, specifically severe heart failure, moderate to severe renal dysfunction, or severely impaired hepatic function (Child-Pugh Class C).
  • Active bleeding or a bleeding disorder.
  • Severe dehydration.

Age and Physiological Status

Population Eligibility Status
Children and Adolescents (under 18) Use Not Established (Safety and efficacy data are insufficient).
Third Trimester of Pregnancy Contraindicated
Breastfeeding/Lactation Contraindicated
Elderly Patients Restricted Use (Start at the lowest dose due to increased risk of side effects).

Conditions for Restricted Use

Caution and monitoring are required for patients with mild to moderate heart, renal, or hepatic impairment; a history of gastrointestinal issues; or uncontrolled hypertension.

Advertisements

What should I know about interactions with other medicines?

The official interaction profile for this medicine, an NSAID, is defined by restrictions on combinations that carry additive risks or alter the clearance of co-administered agents, based on government regulatory documentation.

Documented Interaction Restrictions

Classification Interacting Agents / Outcome Interaction Mechanism (Regulatory Description)
Contraindicated Combinations Other NSAIDs (including COX-2 inhibitors); Lithium; Methotrexate (15 mg/week). Pharmacodynamic Interaction: Additive risk of GI ulceration/bleeding. Exposure-Altering Interaction: Reduced renal clearance, increasing plasma concentrations and toxicity.
Not Recommended Anticoagulants (e.g., Warfarin, Heparins); Oral Corticosteroids; SSRIs; Anti-platelet Agents. Pharmacodynamic Interference: Increased risk of bleeding/hemorrhage and GI ulceration.

Exposure and Clearance Alterations

Official documents note that Dexketoprofen reduces the renal clearance of agents such as Methotrexate (at low doses, < 15 mg/week) and Digoxin, resulting in increased exposure and the potential for elevated plasma levels. Furthermore, co-administration with Ciclosporin or Tacrolimus is associated with an increased risk of nephrotoxicity.

Other Product Interactions

  • Alcohol (Ethanol): Consumption of alcohol is officially documented as increasing the risk of gastrointestinal bleeding.
  • Diuretics and Antihypertensives (e.g., ACE inhibitors/ARBs): Co-administration may diminish the efficacy of these agents and increases the risk of nephrotoxicity.

The interaction profile also notes that elderly patients may be more susceptible to the severity of interaction risks due to a higher likelihood of compromised renal or hepatic function.

Advertisements

Mechanism of Action

How Dexketoprofeno Stada Works

Dexketoprofeno Stada functions primarily through the inhibition of Cyclooxygenase (COX) enzymes, targeting both the COX-1 and COX-2 isoforms. This interaction blocks the catalytic conversion of arachidonic acid into prostanoid compounds. The drug acts as a non-selective inhibitor, initiating the suppression of signaling within the eicosanoid pathways.

The core mechanistic consequence is the marked reduction of prostaglandin and thromboxane generation, which are lipid mediators involved in localized physiological responses. By modifying these early molecular steps, the drug mediates the regulation of processes involving heightened physiological activity, such as nociceptor sensitization and thermoregulation.

This engagement in the mechanistic cascades helps limit the impact of excessive mediator activity associated with processes of sensory transduction (nociception) and core body temperature maintenance (pyresis), resulting in physiological changes characteristic of diminished eicosanoid activity at the systemic level.

Advertisements

Dosage and Administration Information

Administration Method

Dexketoprofeno Stada is available in oral formulations, typically as film-coated tablets. The tablets should be swallowed with a sufficient amount of water.

Relation to Food Intake

For general use, the medication can be taken with food to help minimize the potential for stomach upset. However, in cases of acute or more intense pain, taking the medication on an empty stomach—specifically at least 30 minutes before meals—may allow the active ingredient to be absorbed more rapidly into the bloodstream.

Consistency in Use

To manage symptoms effectively, it is important to follow the schedule provided by a healthcare professional. If the medication is being used for a short-term condition, it is typically discontinued once the symptoms have resolved. For chronic conditions, the duration of use is determined based on individual clinical assessment.

Handling the Medication

  • Keep the tablets in their original blister packaging until use to protect them from light and moisture.
  • Do not crush or chew the tablets unless specifically indicated by the formulation type, as this can affect how the medication is released.
Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Dexketoprofeno Stada


Evidence for Use in Acute Musculoskeletal Pain

Research examined conditions characterized by fluctuating or episodic manifestations such as sprains, muscle strains, or acute low back pain, which primarily consists of short-term randomized controlled trials (RCTs) and observational studies. These trials was evaluated in studies examining patient-reported outcomes describing perceived discomfort. Findings help contextualize how patients reported their experience during short periods of heightened symptom activity.

What remains uncertain is the extent of evidence exploring management of pain over long periods. The follow-up durations were limited, typically lasting only a few days or up to one week. Data are also still emerging regarding its use in patients with more complex or severe pre-existing pain conditions.


Evidence for Use in Acute Dental Pain and Post-operative Settings

The research base for outcomes related to physical discomfort following procedures was evaluated in Randomized Controlled Trials (RCTs) and Meta-analyses. These studies focused on outcomes describing episodic or acute changes in pain, specifically in standardized pain models like post-extraction dental pain and pain after various non-dental surgeries. For post-operative pain, studies research examined outcomes related to the measurement of supplementary opioid doses.

Research highlights a limitation that evidence for acute dental pain is largely restricted to the standardized, severe pain model of third molar surgery; generalizability of the data to other types of dental pain remains uncertain. For post-operative pain, the evidence often was observed in combination with opioids, which can complicate the isolation of its independent focus in all contexts.


Long-term Studies and Follow-up

Research relevant in trials assessing short-term or episodic symptom patterns accounts for the vast majority of the evidence, and as a result, follow-up durations were limited. For the conditions studied, the available evidence contributes to understanding symptom patterns only over days, not weeks, months, or years. Because of this necessary short-term focus, long-term effects are not fully established.


Evidence in Special Populations

Studies examining patient-reported experiences primarily focus on adults who are otherwise generally healthy. For certain groups, data for certain groups remain insufficient. For instance, few data are available for the use of this medicine in children or adolescents. Research was also evaluated in some older adult populations, but evidence suggests findings were mixed, and study design limitations often excluded patients with multiple comorbidities.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Dexketoprofeno Stada (FAQ)


Q: Is Dexketoprofeno Stada the same type of painkiller as Ibuprofen or Naproxen?

A: Dexketoprofeno is classified in the same group of medicines as Ibuprofen and Naproxen, which are all Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). The official product information notes that its specific chemical structure is a single active component (the S-(+)-enantiomer) of the related compound, ketoprofen. This molecular difference contributes to distinguishing it from other NSAIDs.

Q: How long does the pain relief from Dexketoprofeno Stada usually last?

A: The drug is indicated for short-term symptomatic pain relief, and official regimens often suggest administration intervals intended to maintain effective concentrations over several hours. Dosage is typically set to align with the expected duration of pain relief.

Q: Can Dexketoprofeno Stada be used for general headaches or migraines?

A: Official indications list the short-term treatment of acute mild to moderate pain, including musculoskeletal pain, menstrual pain (dysmenorrhea), and toothache. While some product information mentions the use of the active ingredient for conditions like migraine, the primary therapeutic focus described in regulatory documents is for these acute pain types.

Q: Can Dexketoprofeno Stada affect my blood pressure?

A: Official labeling indicates the medicine may affect blood pressure indirectly. NSAIDs as a class may cause fluid retention and swelling, which can influence blood pressure levels. For this reason, use is restricted or contraindicated in patients with severe heart failure or uncontrolled high blood pressure.

Q: What happens if I forget to take my Dexketoprofeno Stada dose?

A: Official patient information advises that a double dose should not be taken to compensate for a missed one. The next dose is typically taken at the regularly scheduled time.

Q: Why is Dexketoprofeno Stada available only with a prescription in some places?

A: In certain countries, regulatory authorities classify the medicine as a Prescription-Only Medicine (POM). This classification is typically due to the potential for rare but serious side effects, particularly involving the gastrointestinal, renal, and cardiovascular systems, which necessitate clinical supervision.

Q: Does Dexketoprofeno Stada contain lactose or other common allergens?

A: The official product information leaflet lists all non-active ingredients, or excipients, used in the medicine's formulation. Patients with known sensitivities or allergies should reference the specific excipients list found on the product packaging or consult a pharmacist.

Q: Can I drive or operate machinery after taking Dexketoprofeno Stada?

A: Official labeling notes that the medicine may slightly affect the ability to drive or operate machinery. This is due to the potential for side effects like dizziness, drowsiness (somnolence), or visual disturbances. If these effects are experienced, official regulatory documents state that driving or operating machinery should be avoided.

Q: What does 'Stada' refer to in the drug name?

A: 'Stada' is the commercial name of the company that manufactures and markets this specific version of the medicine. It is a brand name and not part of the active therapeutic ingredient, which is Dexketoprofen.

Q: Are there known interactions between Dexketoprofeno Stada and common cold remedies?

A: Official regulatory warnings advise against combining this medicine with other NSAIDs (Non-Steroidal Anti-Inflammatory Drugs), as this combination is associated with an increased risk of gastrointestinal side effects. Cold remedies may contain NSAIDs, and therefore the combination should be reviewed carefully.

Q: What should I do if I experience unexpected side effects?

A: Official information advises that if signs of serious side effects occur, such as signs of an allergic reaction (e.g., facial swelling) or gastrointestinal bleeding (e.g., black stools), the use of the medicine should be discontinued. Immediate medical attention is required in cases of severe allergic reactions or gastrointestinal bleeding.

Q: What is the average time until the drug reaches its maximum effect?

A: According to official pharmacokinetic properties described in regulatory documents, the time to reach the maximum plasma concentration (Tmax) after taking the oral tablet is typically very fast, generally ranging between 15 and 45 minutes.

Q: Can Dexketoprofeno Stada be combined with Acetaminophen (Paracetamol)?

A: Official labeling does not list a formal prohibition or contraindication for combining this medicine with paracetamol (Acetaminophen), as their mechanisms of action are generally complementary. However, official documentation indicates that combining pain relievers should be discussed with a healthcare professional.

Q: Can Dexketoprofeno Stada cause dizziness or make me feel sleepy?

A: Yes, dizziness is listed in official documents as a common side effect. Sleepiness, or somnolence, is also officially documented, although it is reported as an uncommon side effect.

Q: Are there any common foods or drinks that should be avoided when taking this medicine?

A: Official regulatory warnings explicitly document that consumption of alcohol increases the risk of gastrointestinal bleeding. Additionally, the medicine is instructed to be taken at least 30 minutes before meals.

Q: What is the main difference between Dexketoprofeno and regular Ketoprofeno?

A: Dexketoprofeno is the single, active form (S-(+)-enantiomer) of the drug ketoprofen. Official documents note that this single-isomer formulation has been associated with a more rapid effect.

Q: Is there any research evidence supporting the use of this drug for joint pain?

A: Official indications list the short-term treatment of acute mild to moderate pain, including musculoskeletal pain. This category includes different types of joint-related discomfort and has been evaluated in clinical studies.

Q: Is there a maximum number of days Dexketoprofeno Stada should be used?

A: The injectable formulation is formally limited to a maximum of two consecutive days. For the oral formulation, official guidelines state that the product is indicated strictly for short-term symptomatic treatment, meaning use should be limited to the symptomatic period.

Q: What kind of pain is Dexketoprofeno Stada best suited to treat?

A: According to regulatory documents, the medicine is officially indicated for the short-term symptomatic treatment of acute mild to moderate pain. This includes common conditions such as acute musculoskeletal pain, menstrual pain (dysmenorrhea), and dental pain.

Q: Can taking Dexketoprofeno Stada affect my liver test results?

A: Regulatory documents note that the medicine's use is constrained in patients with severe liver impairment, and rare cases of hepatic damage are documented as a side effect. Regular checks of liver function are recommended by regulatory documents if longer-term therapy is considered.

Q: What official safety warnings are associated with long-term use of this medicine?

A: The product is not intended for long-term use, as most evidence focuses on short-term relief. If a physician considers longer-term treatment necessary, official documents state that hepatic and renal function and the blood count require regular monitoring. Additionally, long-term use of NSAIDs may be associated with a small increased risk of arterial thrombotic events.

Q: Is Dexketoprofeno Stada used in combination with other medicines for pain management?

A: Clinical trials for post-operative pain relief have shown that the medicine can be part of a multimodal strategy. Regulatory documents note this use can help reduce the amount of supplementary opioid doses required. Regulatory documents emphasize that the medicine must not be combined with any other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), as this combination is formally contraindicated.

Q: Are the reported side effects generally mild or serious?

A: Official regulatory documents classify most reported side effects as Common (such as nausea and dizziness) or Uncommon (such as rash), which are generally mild and temporary. However, serious adverse effects like gastrointestinal bleeding and severe allergic reactions are officially documented as Rare or Very Rare.

Q: How does the mechanism of Dexketoprofeno Stada compare to Celecoxib (a selective COX-2 inhibitor)?

A: Dexketoprofeno is classified as a non-selective inhibitor of the COX enzymes, meaning it targets both COX-1 and COX-2. In contrast, celecoxib is classified as a selective COX-2 inhibitor. Regulatory documents state that combination with any selective COX-2 inhibitor is formally contraindicated.

Advertisements

How should Dexketoprofeno Stada be stored and disposed of?

Storage and Disposal Requirements

Official regulatory documents specify mandatory conditions for storing and disposing of this medicine.

Storage Conditions

  • Temperature: Tablets in PVC-aluminium blister packs must be stored at a temperature not above 30°C. Tablets in other packaging, such as Aclar-aluminium, may not require special temperature conditions.
  • Protection: The medicine must be kept in its original package to ensure protection from light and maintain product stability.
  • Child Safety: Like all medications, this product must be kept out of the sight and reach of children.

Disposal Instructions

Disposal of any unused or expired medicine must be done in accordance with local requirements. The product must not be thrown into household waste or wastewater to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Dexketoprofeno Stada found in:

A-Z Index: